109 related articles for article (PubMed ID: 9511045)
1. Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
Oethinger M; Kern WV; Goldman JD; Levy SB
J Antimicrob Chemother; 1998 Jan; 41(1):111-4. PubMed ID: 9511045
[TBL] [Abstract][Full Text] [Related]
2. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.
Kern WV; Oethinger M; Jellen-Ritter AS; Levy SB
Antimicrob Agents Chemother; 2000 Apr; 44(4):814-20. PubMed ID: 10722475
[TBL] [Abstract][Full Text] [Related]
3. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli.
White DG; Goldman JD; Demple B; Levy SB
J Bacteriol; 1997 Oct; 179(19):6122-6. PubMed ID: 9324261
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.
Oethinger M; Podglajen I; Kern WV; Levy SB
Antimicrob Agents Chemother; 1998 Aug; 42(8):2089-94. PubMed ID: 9687412
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.
Wang H; Dzink-Fox JL; Chen M; Levy SB
Antimicrob Agents Chemother; 2001 May; 45(5):1515-21. PubMed ID: 11302820
[TBL] [Abstract][Full Text] [Related]
6. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli.
Webber MA; Piddock LJ
Antimicrob Agents Chemother; 2001 May; 45(5):1550-2. PubMed ID: 11302826
[TBL] [Abstract][Full Text] [Related]
7. Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli.
Asako H; Nakajima H; Kobayashi K; Kobayashi M; Aono R
Appl Environ Microbiol; 1997 Apr; 63(4):1428-33. PubMed ID: 9097440
[TBL] [Abstract][Full Text] [Related]
8. Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes.
Aono R
Extremophiles; 1998 Aug; 2(3):239-48. PubMed ID: 9783171
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
Lautenbach E; Fishman NO; Metlay JP; Mao X; Bilker WB; Tolomeo P; Nachamkin I
J Infect Dis; 2006 Jul; 194(1):79-85. PubMed ID: 16741885
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
[TBL] [Abstract][Full Text] [Related]
11. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12.
Aono R; Tsukagoshi N; Yamamoto M
J Bacteriol; 1998 Feb; 180(4):938-44. PubMed ID: 9473050
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action and resistance of older and newer fluoroquinolones.
Hooper DC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
[TBL] [Abstract][Full Text] [Related]
13. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA.
Falla TJ; Chopra I
Antimicrob Agents Chemother; 1998 Dec; 42(12):3282-4. PubMed ID: 9835528
[TBL] [Abstract][Full Text] [Related]
14. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Yang J; Luo Y; Cui S; Wang W; Han L
Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
[TBL] [Abstract][Full Text] [Related]
15. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.
Ruiz J; Marco F; Goñi P; Gallardo F; Mensa J; Trilla A; Jimenez de Anta T; Vila J
J Antimicrob Chemother; 1995 Oct; 36(4):737-8. PubMed ID: 8591951
[No Abstract] [Full Text] [Related]
16. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.
Zhao X; Xu C; Domagala J; Drlica K
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13991-6. PubMed ID: 9391140
[TBL] [Abstract][Full Text] [Related]
17. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.
Schneiders T; Amyes SG; Levy SB
Antimicrob Agents Chemother; 2003 Sep; 47(9):2831-7. PubMed ID: 12936981
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
Yamane T; Enokida H; Hayami H; Kawahara M; Nakagawa M
Int J Urol; 2012 Apr; 19(4):360-8. PubMed ID: 22211478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
